NCT01860144 An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase N/A
NCT01858662 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors Status TERMINATED Phase PHASE2
NCT01858649 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. Status COMPLETED Phase PHASE2
NCT01832948 Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01811108 Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer Status COMPLETED Phase N/A
NCT01810744 Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma Status COMPLETED Phase NA
NCT01801904 A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT01791361 Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe Status COMPLETED Phase N/A
NCT01791309 Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01786538 Second-line FOLFOX With or Without Regorafenib in mCRC Patients Failed to First-line Irinotecan Plus Fluoropyrimidines Status WITHDRAWN Phase PHASE3
NCT01767857 A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer Status TERMINATED Phase PHASE3
NCT01754272 A Non-Interventional Follow-Up to the VELOUR Study - Translational Research Status UNKNOWN Phase N/A
NCT01741038 AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2/PHASE3
NCT01733628 Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer Status COMPLETED Phase N/A
NCT01703390 Biomarker Directed Treatment in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2